MCID: MYC008
MIFTS: 59

Myocarditis

Categories: Cardiovascular diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Myocarditis

Summaries for Myocarditis

NIH Rare Diseases : 52 Myocarditis is a condition that is characterized by inflammation of the heart muscle (myocardium). Some affected people have no noticeable symptoms of the condition. When present, signs and symptoms may include chest pain, abnormal heartbeat, shortness of breath, fatigue, signs of infection (i.e. fever, headache, sore throat, diarrhea), and leg swelling. Myocarditis can be caused by a variety of factors including infections (viral, bacterial, parasitic, and fungal), allergic reactions to certain medications, and exposure to certain chemicals. It can also be associated with other inflammatory conditions such as lupus , Wegener's granulomatosis , giant cell arteritis and Takayasu's arteritis . Most cases occur sporadically in people with no family history of the condition. Treatment aims to address the underlying cause of the condition. Medications and rarely, a heart transplant may be needed if the heart muscle becomes weak.

MalaCards based summary : Myocarditis, also known as myocardial inflammation, is related to giant cell myocarditis and rheumatic myocarditis. An important gene associated with Myocarditis is CXADR (CXADR Ig-Like Cell Adhesion Molecule), and among its related pathways/superpathways are Viral myocarditis and Innate Immune System. The drugs Oseltamivir and Adalimumab have been mentioned in the context of this disorder. Affiliated tissues include heart, t cells and endothelial, and related phenotypes are cardiovascular system and cellular

Disease Ontology : 12 An extrinsic cardiomyopathy that is characterized as an inflammation of the heart muscle.

Wikipedia : 74 Myocarditis, also known as inflammatory cardiomyopathy, is inflammation of the heart muscle. Symptoms... more...

Related Diseases for Myocarditis

Diseases in the Myocarditis family:

Acute Myocarditis Autoimmune Myocarditis
Infectious Myocarditis

Diseases related to Myocarditis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 943, show less)
# Related Disease Score Top Affiliating Genes
1 giant cell myocarditis 35.1 MB HLA-B
2 rheumatic myocarditis 34.6 TNNI3 MB
3 toxic myocarditis 34.5 TNNI3 NPPB
4 acute myocarditis 34.4 TNNI3 TNF NPPB CD86 CD40
5 drug reaction with eosinophilia and systemic symptoms 33.4 TNF HLA-B
6 chagas disease 33.0 TNF NPPB NOS2 IL6
7 dilated cardiomyopathy 31.8 TNNI3 TNF NPPB NOS2 MYH6 MB
8 atrial standstill 1 31.8 TNNI3 NPPB MYH6 DSP DMD
9 lupus erythematosus 31.7 TNF HLA-DQB1 CD86 CD40LG CD40
10 congestive heart failure 31.7 TNNI3 TNF NPPB MYH6 IL6
11 sarcoidosis 1 31.7 TNF ICAM1 HLA-DQB1 CD86 CD40LG
12 exanthem 31.7 TNF IL6 CD40LG
13 myositis 31.6 TNF MB IL6 HLA-B DMD
14 cardiac sarcoidosis 31.6 TNF HLA-DQB1 DSP
15 chickenpox 31.6 TNF IL6 CD40LG
16 endocarditis 31.6 TNNI3 TNF IL6
17 autoimmune disease 31.5 TNF IL6 HLA-DQB1 HLA-B CD86 CD55
18 pericarditis 31.5 TNNI3 TNF NPPB IL6 CD40LG
19 cardiac arrest 31.5 NPPB MYH6 ICAM1 DSP
20 mumps 31.5 TNF IL6 HLA-DQB1 CD40LG
21 pericardial effusion 31.5 TNNI3 NPPB IL6 CD40LG
22 typhoid fever 31.4 TNF IL6 HLA-DQB1 CD40LG
23 poliomyelitis 31.4 TNF ICAM1 CD40LG
24 vasculitis 31.4 TNF ITGB2 IL6 ICAM1 HLA-B CD40LG
25 myasthenia gravis 31.4 TNF HLA-DQB1 HLA-B CD86 CD55 CD40LG
26 encephalitis 31.4 TNF NOS2 IL6 CD40LG
27 meningoencephalitis 31.4 TNF IL6 CD40LG
28 chlamydia 31.3 TNF NOS2 IL6 CD40LG
29 q fever 31.3 TNF IL6 CD40LG
30 pharyngitis 31.3 TNF IL6 CD40LG
31 dengue disease 31.2 TNF ICAM1 CD40LG
32 pneumonia 31.2 TNF MB IL6 ICAM1 CD40LG
33 kawasaki disease 31.2 TNF NPPB IL6 CD40LG CD40
34 leptospirosis 31.2 TNF IL6 ICAM1 CD40LG
35 arrhythmogenic right ventricular cardiomyopathy 31.2 NPPB MYH6 DSP DMD DAG1
36 chlamydia pneumonia 31.2 TNF IL6 CD40LG
37 lyme disease 31.2 TNF IL6 HLA-DQB1 CD40LG
38 toxoplasmosis 31.2 TNF NOS2 IL6 HLA-DQB1 CD40LG CD40
39 guillain-barre syndrome 31.2 TNF HLA-DQB1 CD40LG
40 respiratory failure 31.2 TNF NPPB IL6 DMD CD40LG
41 cytomegalovirus infection 31.1 TNF IL6 HLA-B
42 mixed connective tissue disease 31.1 TNF IL6 CD40LG
43 toxic shock syndrome 31.1 TNF NOS2 IL6 CD86 CD40LG CD40
44 proteasome-associated autoinflammatory syndrome 1 31.1 TNF NOS2 IL6 ICAM1
45 bronchopneumonia 31.1 TNF IL6 CD40LG
46 severe acute respiratory syndrome 31.1 TNF IL6 CD40LG
47 brucellosis 31.1 TNF IL6 CD86 CD40LG
48 acute myocardial infarction 31.1 TNNI3 TNF NPPB MB IL6
49 acquired immunodeficiency syndrome 31.1 TNF NOS2 IL6 ICAM1 HLA-B CD40LG
50 rubella 31.1 TNF IL6 HLA-DQB1 HLA-B CD40LG
51 dengue hemorrhagic fever 31.1 TNF IL6 CD40LG
52 glomerulonephritis 31.1 NOS2 ICAM1 CD55 CD40LG
53 rheumatic heart disease 31.0 TNF NPPB IL6 HLA-DQB1
54 left bundle branch hemiblock 31.0 TNNI3 NPPB DSP
55 common cold 31.0 TNF IL6 ICAM1
56 orchitis 31.0 TNF IL6 CD40LG
57 systemic lupus erythematosus 31.0 TNF ITGB2 IL6 ICAM1 HLA-DQB1 CD86
58 purpura 31.0 TNF IL6 CD40LG
59 immune deficiency disease 31.0 TNF ITGB2 IL6 HLA-B CD86 CD40LG
60 pulmonary edema 31.0 TNNI3 TNF NPPB NOS2 ICAM1
61 rheumatic fever 31.0 TNF NPPB IL6 ICAM1 HLA-DQB1 CD40LG
62 thrombocytopenia 31.0 TNF IL6 ICAM1 HLA-B CD86 CD40LG
63 meningitis 31.0 TNF IL6 ICAM1 HLA-B CD55 CD40LG
64 infective endocarditis 31.0 TNNI3 TNF IL6
65 acute cystitis 31.0 TNF IL6 CD40LG
66 tetanus 31.0 TNF MB IL6 CD40LG
67 bacterial infectious disease 30.9 TNF ITGB2 IL6 CD86 CD40LG
68 erythema multiforme 30.9 TNF IL6 ICAM1 DSP
69 mitral valve insufficiency 30.9 TNNI3 NPPB MYH6
70 viral pneumonia 30.9 TNF IL6 CD40LG
71 scorpion envenomation 30.9 TNF IL6
72 myelitis 30.9 TNF IL6 CD40LG
73 mycoplasma pneumoniae pneumonia 30.9 TNF IL6 CD40LG
74 conjunctivitis 30.9 TNF IL6 ICAM1 HLA-B
75 viral encephalitis 30.8 TNF IL6 CD40LG
76 severe cutaneous adverse reaction 30.8 TNF HLA-DQB1 HLA-B CD40LG
77 erysipelas 30.8 TNF IL6 CD40LG
78 trypanosomiasis 30.8 TNF NOS2 IL6 ICAM1
79 coronary stenosis 30.8 TNNI3 NPPB IL6 ICAM1
80 peritonitis 30.8 TNF NOS2 ITGB2 IL6 ICAM1
81 dengue shock syndrome 30.7 TNF IL6 CD40LG
82 myocardial infarction 30.7 TNNI3 TNF NPPB MYH6 MB IL6
83 legionellosis 30.7 TNF IL6 CD40LG
84 gas gangrene 30.7 TNNI3 MB IL6 DMD DAG1
85 disseminated intravascular coagulation 30.7 TNF MB IL6
86 plasmodium vivax malaria 30.7 TNF IL6 ICAM1 CD40LG CD40
87 atherosclerosis susceptibility 30.7 TNF IL6 ICAM1 CD40
88 herpes zoster 30.7 TNF HLA-B CD40LG
89 angina pectoris 30.7 TNNI3 NPPB MB IL6
90 takayasu arteritis 30.7 TNF IL6 ICAM1 HLA-B CD40LG
91 aortitis 30.7 TNF IL6 CD40LG
92 viral infectious disease 30.7 TNF IL6 ICAM1 HLA-B CXADR CD40LG
93 graft-versus-host disease 30.7 TNF IL6 HLA-DQB1 HLA-B
94 bacterial sepsis 30.7 TNF NOS2 IL6
95 chorioretinitis 30.7 TNF IL6 CD40LG
96 autoimmune hepatitis 30.7 TNF IL6 HLA-DQB1 CD40LG
97 histoplasmosis 30.7 TNF HLA-B CD40LG
98 restrictive cardiomyopathy 30.7 TNNI3 NPPB MYH6 DSP DMD
99 amyloidosis 30.7 TNNI3 TNF NPPB IL6 CD40LG
100 arthritis 30.7 TNF ITGB2 IL6 ICAM1 HLA-DQB1 HLA-B
101 inflammatory bowel disease 30.6 TNF NOS2 ITGB2 IL6 ICAM1 HLA-DQB1
102 celiac disease 1 30.6 TNF IL6 HLA-DQB1 HLA-B CD86 CD40LG
103 pulmonary embolism 30.6 TNNI3 NPPB MB CD40LG
104 coronavirus infectious disease 30.6 TNF IL6 CD40LG
105 myopathy 30.6 TNNI3 NOS2 MYH6 MB IL6 HLA-B
106 hypertrophic cardiomyopathy 30.6 TNNI3 TNF NPPB MYH6 MB IL6
107 syphilis 30.6 TNF IL6 CD40LG
108 graves' disease 30.6 ICAM1 HLA-DQB1 HLA-B CD40
109 cryoglobulinemia 30.6 TNF IL6 CD40LG
110 uveitis 30.6 TNF IL6 ICAM1 HLA-B
111 hashimoto thyroiditis 30.6 TNF IL6 ICAM1 HLA-DQB1 HLA-B CD40
112 otitis media 30.5 TNF IL6 ICAM1 CD40LG
113 lung disease 30.5 TNF NPPB IL6 ICAM1 CD40LG
114 myeloma, multiple 30.5 TNF IL6 ICAM1 CD86 CD40LG CD40
115 leprosy 3 30.5 TNF IL6 CD40LG
116 bronchiolitis 30.5 TNF IL6 CD40LG
117 muscular dystrophy, duchenne type 30.5 TNNI3 MB DMD DAG1
118 bacterial pneumonia 30.5 TNF IL6 CD40LG
119 dystrophinopathies 30.5 TNF NOS2 DMD
120 pityriasis rosea 30.4 HLA-DQB1 HLA-B CD40LG
121 reactive arthritis 30.4 TNF IL6 HLA-B
122 endophthalmitis 30.4 TNF IL6 ICAM1
123 spondylitis 30.4 TNF IL6 HLA-B
124 systolic heart failure 30.4 TNF NPPB IL6
125 acute disseminated encephalomyelitis 30.4 HLA-DQB1 HLA-B CD40LG
126 dermatitis herpetiformis 30.4 TNF HLA-DQB1 CD40LG
127 temporal arteritis 30.4 TNF IL6 CD40LG
128 psoriatic arthritis 30.4 TNF IL6 HLA-B CD40LG
129 monoclonal gammopathy of uncertain significance 30.4 TNF IL6 CD40LG
130 burkitt lymphoma 30.4 TNF IL6 ICAM1 CD55 CD40LG CD40
131 cutaneous lupus erythematosus 30.4 TNF IL6 ICAM1 CD40LG
132 peripheral nervous system disease 30.4 TNF IL6 DMD CD40LG
133 arteries, anomalies of 30.4 TNNI3 TNF MIR590 IL6 ICAM1
134 heart disease 30.4 TNNI3 TNF NPPB NOS2 MYH6 MB
135 left ventricular noncompaction 30.4 TNNI3 MYH6 DSP DMD
136 echinococcosis 30.4 TNF IL6 HLA-B CD40LG
137 vascular disease 30.3 TNF NPPB NOS2 IL6 ICAM1 CD40LG
138 atrial heart septal defect 30.3 TNNI3 NPPB MYH6 DMD
139 intermediate coronary syndrome 30.3 TNNI3 MB IL6
140 parasitic helminthiasis infectious disease 30.3 TNF IL6 CD40LG
141 apnea, obstructive sleep 30.3 TNF NPPB IL6
142 aplastic anemia 30.3 TNF IL6 HLA-DQB1 HLA-B CD55
143 relapsing-remitting multiple sclerosis 30.3 TNF IL6 ICAM1 CD40LG
144 wolff-parkinson-white syndrome 30.3 TNNI3 NPPB MYH6
145 malaria 30.3 TNF NOS2 MB ITGB2 IL6 ICAM1
146 interstitial lung disease 30.3 TNF NPPB IL6 ICAM1 CD40LG
147 sleep apnea 30.3 TNF NPPB IL6 ICAM1
148 cystitis 30.3 TNF NOS2 IL6 ICAM1
149 primary biliary cirrhosis 30.3 TNF IL6 ICAM1 HLA-DQB1 HLA-B CD86
150 gingivitis 30.2 TNF IL6 ICAM1
151 demyelinating disease 30.2 TNF ITGB2 IL6 ICAM1 CD40LG
152 panuveitis 30.2 TNF IL6 HLA-DQB1 HLA-B CD40LG
153 nervous system disease 30.2 TNF NOS2 MIR590 IL6
154 dermatitis, atopic 30.2 TNF IL6 ICAM1 CD86 CD40
155 pemphigus 30.2 TNF IL6 HLA-DQB1 DSP CD40LG
156 lipoprotein quantitative trait locus 30.2 TNNI3 TNF NPPB MYH6 MB IL6
157 varicose veins 30.2 TNF IL6 ICAM1
158 parasitic protozoa infectious disease 30.2 TNF IL6 ICAM1 CD86 CD40LG CD40
159 rheumatoid arthritis 30.2 TNF NOS2 ITGB2 IL6 ICAM1 HLA-DQB1
160 plasmodium falciparum malaria 30.2 TNF NOS2 MB IL6 ICAM1 CD55
161 limb ischemia 30.1 TNNI3 TNF IL6 ICAM1
162 spondyloarthropathy 30.1 TNF IL6 HLA-B
163 periventricular leukomalacia 30.1 TNF NPPB NOS2 IL6
164 multiple sclerosis 30.1 TNF NOS2 ITGB2 IL6 ICAM1 HLA-DQB1
165 asthma 30.1 TNF NOS2 MB ITGB2 IL6 ICAM1
166 spondyloarthropathy 1 30.1 TNF HLA-B CD40LG
167 leishmaniasis 30.1 TNF NOS2 ITGB2 IL6 HLA-DQB1 CD40
168 brugada syndrome 30.1 TNNI3 MYH6 DSP DMD
169 diabetes mellitus 30.1 TNF NPPB NOS2 ITGB2 IL6 ICAM1
170 pre-eclampsia 30.1 TNF NOS2 IL6 ICAM1 CD40LG
171 common variable immunodeficiency 30.0 TNF IL6 HLA-DQB1 HLA-B CD86 CD40LG
172 aortic valve disease 2 30.0 TNNI3 NPPB MYH6 MIR590
173 central nervous system disease 30.0 TNF NOS2 MIR590 IL6
174 fabry disease 29.9 TNNI3 TNF NPPB IL6 ICAM1
175 lymphoma, non-hodgkin, familial 29.9 TNF MIR590 IL6 CD86 CD55 CD40LG
176 diabetes mellitus, type i 29.8 TNF NOS2 IL6 ICAM1 HLA-DQB1 HLA-B
177 pulmonary disease, chronic obstructive 29.7 TNF NPPB MB IL6
178 hypertension, essential 29.0 TNNI3 TNF NPPB NOS2 MYH6 MIR590
179 septic myocarditis 12.7
180 autoimmune myocarditis 12.6
181 fiedler's myocarditis 12.6
182 interstitial myocarditis 12.4
183 infectious myocarditis 12.4
184 diphtheria 11.7
185 trichinosis 11.7
186 influenza 11.6
187 odontoma-dysphagia syndrome 11.2
188 spondylometaphyseal dysplasia, sedaghatian type 11.2
189 cardiogenic shock 10.9
190 rheumatic fever-related antigen 10.8
191 light fixation seizure syndrome 10.8 CD40LG CD40
192 external pathological resorption 10.8 TNF IL6
193 annular erythema 10.7 ITGB2 ICAM1
194 epstein-barr virus hepatitis 10.7 HLA-B CD40LG
195 pustulosis palmaris et plantaris 10.7 TNF ITGB2 CD40LG
196 immunodeficiency with hyper-igm, type 3 10.7 CD86 CD40LG CD40
197 anaerobic pneumonia 10.7 TNF IL6 CD40
198 tenosynovitis 10.7 TNF IL6 CD40LG
199 blastomycosis 10.7 TNF IL6 CD40LG
200 scleral disease 10.7 TNF IL6 CD40LG
201 lung abscess 10.7 TNF IL6 CD40LG
202 idiopathic anterior uveitis 10.7 TNF IL6
203 amebiasis 10.7 TNF ICAM1 CD40LG
204 idiopathic neutropenia 10.7 TNF IL6 CD40LG
205 laryngitis 10.7 TNF IL6 CD40LG
206 african tick-bite fever 10.7 TNF IL6 CD40LG
207 epididymis disease 10.7 TNF IL6 CD40LG
208 background diabetic retinopathy 10.7 TNF IL6 ICAM1
209 vaginal discharge 10.7 TNF IL6 CD40LG
210 trichomoniasis 10.7 TNF IL6 CD40LG
211 heterophyiasis 10.7 ICAM1 CD40LG
212 fungal meningitis 10.7 TNF IL6 CD40LG
213 central nervous system vasculitis 10.7 TNF IL6 CD40LG
214 urethritis 10.7 TNF IL6 CD40LG
215 tendinitis 10.7 TNF IL6 CD40LG
216 hypopyon 10.7 TNF IL6 HLA-B
217 moyamoya angiopathy 10.7 HLA-DQB1 HLA-B
218 polyradiculopathy 10.7 TNF IL6 CD40LG
219 beryllium disease 10.7 TNF HLA-DQB1
220 primary systemic mycosis 10.7 TNF IL6 CD40LG
221 alveolar echinococcosis 10.7 TNF HLA-DQB1 HLA-B
222 streptococcal toxic-shock syndrome 10.7 TNF IL6
223 pneumocystosis 10.7 TNF IL6 CD40LG
224 hypersensitivity vasculitis 10.7 TNF IL6 CD40LG
225 cecal disease 10.7 TNF IL6 CD40LG
226 pyelitis 10.7 TNF IL6 CD40LG
227 angioimmunoblastic lymphadenopathy with dysproteinemia 10.7 TNF IL6
228 macular retinal edema 10.7 TNF IL6 ICAM1
229 hypersensitivity reaction type iii disease 10.7 TNF IL6 CD40LG
230 autoimmune disease of peripheral nervous system 10.7 TNF IL6 CD40LG
231 streptococcus pneumonia 10.7 TNF IL6 CD40LG
232 fallopian tube disease 10.7 TNF IL6 CD40LG
233 pure red-cell aplasia 10.7 HLA-DQB1 HLA-B CD40LG
234 plasma protein metabolism disease 10.7 TNF IL6 CD40LG
235 autoimmune disease of cardiovascular system 10.7 TNF IL6 CD40LG
236 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.7
237 autoimmune disease of blood 10.7 TNF IL6 CD40LG
238 lacrimal apparatus disease 10.7 TNF IL6 ICAM1
239 intermediate uveitis 10.7 TNF IL6 HLA-B
240 leukostasis 10.7 TNF IL6 ICAM1
241 pyoderma 10.7 TNF ITGB2 CD40LG
242 atrioventricular block 10.7
243 arthus reaction 10.7 TNF NOS2 ICAM1
244 herpangina 10.7 TNF IL6 CD40LG
245 autoimmune disease of exocrine system 10.7 TNF IL6 CD40LG
246 microscopic colitis 10.7 TNF IL6 HLA-DQB1
247 middle ear disease 10.7 TNF IL6 CD40LG
248 endocardium disease 10.7 TNF IL6 CD40LG
249 splenic disease 10.7 TNF IL6 CD40LG
250 trachoma 10.7 TNF IL6 HLA-B
251 spotted fever rickettsiosis 10.7 TNF NOS2
252 coccidiosis 10.7 TNF IL6 CD40LG
253 conjunctival disease 10.7 TNF IL6 CD40LG
254 eales disease 10.7 TNF NOS2 IL6
255 hepatic vascular disease 10.7 TNF IL6 CD40LG
256 dysentery 10.7 TNF IL6 CD40LG
257 endometritis 10.6 TNF IL6 HLA-DQB1
258 hantavirus hemorrhagic fever with renal syndrome 10.6 TNF IL6 CD55 CD40LG
259 paracoccidioidomycosis 10.6 TNF IL6 CD86 CD40LG
260 paranasal sinus disease 10.6 TNF IL6 CD40LG
261 hypereosinophilic syndrome 10.6
262 rectal disease 10.6 TNF IL6 CD40LG
263 lymphocytic choriomeningitis 10.6 IL6 DAG1 CD86
264 plague 10.6 TNF IL6 CD86
265 opportunistic mycosis 10.6 TNF IL6 CD40LG
266 leukemia, acute monocytic 10.6 TNF IL6 CD40
267 paraneoplastic pemphigus 10.6 HLA-DQB1 HLA-B DSP
268 lichen disease 10.6 TNF IL6 ICAM1 CD40LG
269 cytomegalovirus retinitis 10.6 TNF HLA-DQB1 HLA-B CD40LG
270 progressive muscular dystrophy 10.6 MB DMD
271 spinal cord disease 10.6 TNF IL6 CD40LG
272 compartment syndrome 10.6 TNF MB IL6
273 iritis 10.6 TNF IL6 HLA-B CD40LG
274 ectodermal dysplasia 1, hypohidrotic, x-linked 10.6 TNF IL6 ICAM1
275 iridocyclitis 10.6 TNF IL6 HLA-B CD40LG
276 vein disease 10.6 TNF IL6 ICAM1 CD40LG
277 retinal vein occlusion 10.6 TNF IL6 CD40LG
278 nose disease 10.6 TNF IL6 ICAM1 CD40LG
279 autoimmune disease of endocrine system 10.6 TNF IL6 CD40LG CD40
280 fungal infectious disease 10.6 TNF IL6 CD40LG
281 plasma cell leukemia 10.6 IL6 ICAM1 CD40
282 b cell deficiency 10.6 TNF IL6 CD40LG CD40
283 pulpitis 10.6 TNF NOS2 IL6
284 endocrine exophthalmos 10.6 IL6 CD40LG
285 bone structure disease 10.6 TNF IL6 DMD
286 lymph node disease 10.6 TNF IL6 CD40LG
287 spinal cord injury 10.6 TNF NOS2 IL6
288 hypersensitivity reaction type iv disease 10.6 TNF IL6 CD40LG
289 sickle cell anemia 10.6 TNF IL6 ICAM1 CD40LG
290 autoimmune disease of gastrointestinal tract 10.6 TNF IL6 HLA-DQB1 CD40LG
291 aphthous stomatitis 10.6 TNF IL6 HLA-B CD40
292 salivary gland disease 10.6 TNF IL6 CD40LG
293 uveal disease 10.6 TNF IL6 HLA-B CD40LG
294 bronchial disease 10.6 TNF IL6 ICAM1 CD40LG
295 hemopericardium 10.6
296 keratoconjunctivitis 10.6 TNF IL6 ICAM1
297 sclerosing cholangitis 10.6 TNF IL6 HLA-B CD40LG
298 cholangitis 10.6 TNF IL6 HLA-B CD40LG
299 commensal bacterial infectious disease 10.6 TNF IL6 CD40LG
300 toxicodendron dermatitis 10.6 TNF ICAM1
301 isolated elevated serum creatine phosphokinase levels 10.6 MB DMD DAG1
302 chronic beryllium disease 10.6 TNF HLA-DQB1
303 cystic echinococcosis 10.6 IL6 HLA-DQB1 HLA-B CD40LG
304 autoimmune disease of skin and connective tissue 10.6 TNF IL6 DSP CD40LG
305 integumentary system disease 10.6 TNF IL6 ICAM1 CD40LG
306 allergic contact dermatitis 10.6 TNF IL6 ICAM1
307 acute kidney tubular necrosis 10.6 TNF MB IL6 CD40LG
308 cellulitis 10.6 TNF IL6 DSP CD40LG
309 contact dermatitis 10.6 TNF IL6 ICAM1
310 hair disease 10.6 TNF IL6 DSP CD40LG
311 ileus 10.6 TNF IL6 ICAM1
312 testicular disease 10.6 TNF IL6 CD40LG
313 autoimmune disease of musculoskeletal system 10.6 TNF IL6 CD86 CD40LG CD40
314 cranial nerve disease 10.6 TNF IL6 CD40LG
315 primary bacterial infectious disease 10.6 TNF IL6 CD86 CD40LG CD40
316 malignant hyperthermia 10.6 MYH6 MB IL6 DMD
317 x-linked recessive disease 10.6 TNF IL6 DMD DAG1 CD40LG
318 x-linked monogenic disease 10.6 TNF IL6 DMD DAG1 CD40LG
319 cardiac conduction defect 10.6
320 allergic hypersensitivity disease 10.6
321 primary progressive multiple sclerosis 10.6 TNF ICAM1 HLA-DQB1
322 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 10.5 TNF IL6 ICAM1
323 varicocele 10.5 TNF NOS2 IL6
324 filariasis 10.5 TNF NOS2 IL6
325 alopecia areata 10.5 TNF IL6 ICAM1 HLA-DQB1 HLA-B
326 familial isolated dilated cardiomyopathy 10.5 TNNI3 MYH6 DMD
327 cutaneous leishmaniasis 10.5 TNF NOS2 IL6
328 blood coagulation disease 10.5 TNF IL6 CD40LG
329 narcolepsy 10.5 TNF IL6 HLA-DQB1 HLA-B
330 mantle cell lymphoma 10.5 TNF IL6 CD40LG CD40
331 iron deficiency anemia 10.5 TNF MB IL6
332 ischemia 10.5
333 lichen planus 10.5 TNF IL6 ICAM1
334 castleman disease 10.5 IL6 ICAM1 DSP
335 autoimmune disease of central nervous system 10.5 TNF IL6 ICAM1 CD86 CD40LG CD40
336 peripheral artery disease 10.5 TNF NPPB IL6 ICAM1
337 retinal vascular disease 10.5 TNF IL6 ICAM1
338 behcet syndrome 10.5 TNF IL6 ICAM1 HLA-B CD40LG CD40
339 bile duct disease 10.5 TNF MIR590 IL6 CD40LG
340 biliary tract disease 10.5 TNF MIR590 IL6 CD40LG
341 mature b-cell neoplasm 10.5 IL6 CD40LG CD40
342 intracranial berry aneurysm 10.5 TNNI3 TNF IL6 ICAM1
343 ventricular fibrillation, paroxysmal familial, 1 10.5
344 progressive familial heart block, type ia 10.5
345 alcoholic hepatitis 10.5 TNF IL6 ICAM1
346 muscle tissue disease 10.5 TNF MYH6 MB IL6 DMD DAG1
347 muscular disease 10.5 TNF MYH6 MB IL6 DMD DAG1
348 tricuspid valve disease 10.4 TNNI3 NPPB MYH6
349 combined t cell and b cell immunodeficiency 10.4 TNF ITGB2 IL6 ICAM1 CD86 CD40LG
350 cerebrovascular disease 10.4 TNF NPPB IL6 ICAM1 CD40LG
351 lymphoid interstitial pneumonia 10.4 TNF IL6 CD40LG
352 psoriasis 10.4 TNF ITGB2 IL6 ICAM1 HLA-B CD40
353 nontuberculous mycobacterial lung disease 10.4 TNF HLA-B
354 eye disease 10.4 TNF IL6 ICAM1 DMD CD40LG
355 polymyositis 10.4
356 urinary system disease 10.4 TNF MIR590 IL6 CD40LG
357 thymoma, familial 10.4
358 thymoma 10.4
359 immune system disease 10.4 TNF MIR590 IL6 CD40LG
360 potocki-shaffer syndrome 10.4 TNF IL6 CD40LG
361 syncope 10.4
362 churg-strauss syndrome 10.4
363 null-cell leukemia 10.4 TNF IL6
364 pulmonary artery disease 10.4 TNNI3 NPPB IL6 CD40LG
365 patent foramen ovale 10.4 TNNI3 NPPB MYH6 CD40LG
366 leukemia, chronic lymphocytic 10.4 TNF ITGB2 IL6 ICAM1 CD86 CD55
367 cardiac tamponade 10.3
368 heart conduction disease 10.3 TNNI3 NPPB MYH6
369 covid-19 10.3
370 skin disease 10.3 TNF ITGB2 IL6 ICAM1 HLA-B DSP
371 variola major 10.3
372 smallpox 10.3
373 allergic angiitis 10.3
374 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.3
375 acute kidney failure 10.3
376 ulcerative colitis 10.3
377 cytokine deficiency 10.3
378 aneurysm 10.3
379 pheochromocytoma 10.3
380 adrenal gland pheochromocytoma 10.3
381 colitis 10.3
382 progressive familial heart block, type ib 10.3
383 right bundle branch block 10.3
384 osteoporosis 10.2 TNF NPPB IL6 ICAM1 CD40LG CD40
385 pfeiffer syndrome 10.2
386 herpes simplex 10.2
387 adult-onset still's disease 10.2
388 fibrosis of extraocular muscles, congenital, 1 10.2
389 peripartum cardiomyopathy 10.2
390 tonsillitis 10.2
391 diarrhea 10.2
392 gastroenteritis 10.2
393 pericardium disease 10.2 TNNI3 TNF NPPB MB IL6 CD40LG
394 connective tissue disease 10.2
395 cardiovascular system disease 10.2 TNF NPPB NOS2 MIR590 IL6 ICAM1
396 sudden infant death syndrome 10.2
397 coronary heart disease 1 10.2
398 granulomatosis with polyangiitis 10.2
399 hepatitis 10.2
400 blood platelet disease 10.2 TNF IL6 CD40LG
401 hypereosinophilic syndrome, idiopathic 10.2
402 enthesopathy 10.2
403 severe combined immunodeficiency 10.2
404 47,xyy 10.2
405 hypoplastic left heart syndrome 10.2 TNNI3 NPPB MYH6
406 neuromuscular disease 10.2 MYH6 MB DMD DAG1
407 scleroderma, familial progressive 10.1
408 pulmonary hypertension 10.1
409 spotted fever 10.1
410 kidney disease 10.1
411 thyroiditis 10.1
412 crohn's disease 10.1
413 encephalopathy 10.1
414 hepatitis c virus 10.1
415 pancreatitis 10.1
416 measles 10.1
417 48,xyyy 10.1
418 human immunodeficiency virus type 1 10.1
419 pertussis 10.1
420 intrinsic cardiomyopathy 10.1 TNNI3 NPPB MYH6 MIR590 DSP DMD
421 cardiac arrhythmia 10.1
422 atrioventricular dissociation 10.1
423 endocardial fibroelastosis 10.1
424 third-degree atrioventricular block 10.1
425 constrictive pericarditis 10.1
426 aseptic meningitis 10.1
427 endomyocardial fibrosis 10.1
428 mitral valve stenosis 10.1
429 hepatitis c 10.1
430 mouth disease 10.1
431 systemic scleroderma 10.1
432 muscular dystrophy 10.1
433 posttransplant acute limbic encephalitis 10.1
434 orthostatic intolerance 10.1
435 legionnaire disease 10.1
436 leukemia, acute lymphoblastic 10.1
437 parotitis 10.1
438 interstitial nephritis 10.1
439 rabies 10.1
440 heart septal defect 10.1
441 schizoaffective disorder 10.1
442 broken heart syndrome 10.1
443 granulocytopenia 10.1
444 renal cell carcinoma, nonpapillary 10.0
445 west nile virus 10.0
446 hyperlipoproteinemia, type iii 10.0
447 epidemic typhus 10.0
448 ptosis 10.0
449 dermatomyositis 10.0
450 neutropenia 10.0
451 sick sinus syndrome 10.0
452 acute pancreatitis 10.0
453 hemolytic anemia 10.0
454 hyperthyroidism 10.0
455 meningococcemia 10.0
456 portal hypertension 10.0 TNF NOS2 CD40LG
457 ocular motor apraxia 10.0
458 diabetes mellitus, ketosis-prone 10.0
459 dengue virus 10.0
460 atrial fibrillation 10.0
461 visual epilepsy 10.0
462 coronary artery vasospasm 10.0
463 scrub typhus 10.0
464 ventricular septal defect 10.0
465 neuritis 10.0
466 thymic carcinoma 10.0
467 vaccinia 10.0
468 juvenile rheumatoid arthritis 10.0
469 orbital plasma cell granuloma 10.0
470 toxocariasis 10.0
471 seizure disorder 10.0
472 atrial standstill 10.0
473 extrinsic cardiomyopathy 10.0 TNNI3 TNF NPPB MYH6 MIR590 IL6
474 enterocolitis 10.0
475 chikungunya 10.0
476 metabolic acidosis 10.0
477 drug allergy 10.0
478 hepatitis a 10.0
479 alcoholic cardiomyopathy 10.0
480 polyneuropathy 10.0
481 hepatitis b 10.0
482 pulmonary tuberculosis 10.0
483 heart valve disease 10.0
484 tricuspid valve insufficiency 10.0
485 liver cirrhosis 10.0
486 inferior myocardial infarction 10.0
487 antisynthetase syndrome 10.0
488 heparin-induced thrombocytopenia 10.0
489 neisseria meningitidis infection 10.0
490 back pain 10.0
491 headache 10.0
492 small cell cancer of the lung 9.9
493 graves disease 1 9.9
494 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.9
495 ataxia and polyneuropathy, adult-onset 9.9
496 kearns-sayre syndrome 9.9
497 major affective disorder 8 9.9
498 major affective disorder 9 9.9
499 melanoma, cutaneous malignant 10 9.9
500 juvenile arthritis 9.9
501 deficiency anemia 9.9
502 rocky mountain spotted fever 9.9
503 lymphoma 9.9
504 salmonellosis 9.9
505 hemiplegia 9.9
506 ornithosis 9.9
507 hemosiderosis 9.9
508 pancytopenia 9.9
509 boutonneuse fever 9.9
510 hypothyroidism 9.9
511 viral hepatitis 9.9
512 melanoma 9.9
513 dermatitis 9.9
514 antiphospholipid syndrome 9.9
515 bipolar disorder 9.9
516 gastritis 9.9
517 intracranial embolism 9.9
518 scarlet fever 9.9
519 erythema infectiosum 9.9
520 exophthalmos 9.9
521 allergic encephalomyelitis 9.9
522 cardiac rupture 9.9
523 coronary artery aneurysm 9.9
524 macrophage activation syndrome 9.9
525 erythema multiforme major 9.9
526 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.9
527 triiodothyronine receptor auxiliary protein 9.8
528 vitiligo-associated multiple autoimmune disease susceptibility 6 9.8
529 lung cancer 9.8
530 heart block, congenital 9.8
531 hydrops fetalis, nonimmune 9.8
532 vitiligo-associated multiple autoimmune disease susceptibility 1 9.8
533 mycobacterium tuberculosis 1 9.8
534 autoimmune cardiomyopathy 9.8
535 first-degree atrioventricular block 9.8
536 second-degree atrioventricular block 9.8
537 crohn's colitis 9.8
538 thrombosis 9.8
539 ehrlichiosis 9.8
540 hydrocephalus 9.8
541 adult respiratory distress syndrome 9.8
542 hypertensive heart disease 9.8
543 paranoid schizophrenia 9.8
544 candidiasis 9.8
545 alcohol use disorder 9.8
546 cholecystitis 9.8
547 granulomatous hepatitis 9.8
548 thrombophilia 9.8
549 agammaglobulinemia 9.8
550 pulmonary fibrosis 9.8
551 hepatitis e 9.8
552 hypokalemia 9.8
553 aortic valve insufficiency 9.8
554 mitral valve disease 9.8
555 bronchitis 9.8
556 subacute delirium 9.8
557 diastolic heart failure 9.8
558 splenomegaly 9.8
559 west nile virus infection 9.8
560 raynaud phenomenon 9.8
561 brain injury 9.8
562 dysphagia 9.8
563 acute liver failure 9.8
564 alcohol dependence 9.8
565 marfan syndrome 9.8
566 pulmonary hemosiderosis 9.8
567 schistosoma mansoni infection, susceptibility/ 9.8
568 tetralogy of fallot 9.8
569 anemia, autoimmune hemolytic 9.8
570 lymphoma, hodgkin, classic 9.8
571 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.8
572 sjogren syndrome 9.8
573 helicobacter pylori infection 9.8
574 cd4/cd8 t-cell ratio 9.8
575 stroke, ischemic 9.8
576 lung cancer susceptibility 3 9.8
577 cyanosis, transient neonatal 9.8
578 aspergillosis 9.8
579 muscle hypertrophy 9.8
580 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
581 human monocytic ehrlichiosis 9.8
582 keshan disease 9.8
583 hemophagocytic lymphohistiocytosis 9.8
584 aspiration pneumonia 9.8
585 follicular lymphoma 9.8
586 stuttering 9.8
587 purpura fulminans 9.8
588 myoglobinuria 9.8
589 meningococcal meningitis 9.8
590 middle east respiratory syndrome 9.8
591 aortic dissection 9.8
592 osteomyelitis 9.8
593 siderosis 9.8
594 epidemic pleurodynia 9.8
595 retinal microaneurysm 9.8
596 pyelonephritis 9.8
597 coronary thrombosis 9.8
598 esophagitis 9.8
599 cutaneous diphtheria 9.8
600 shigellosis 9.8
601 hemolytic-uremic syndrome 9.8
602 megaesophagus 9.8
603 porphyria 9.8
604 klebsiella pneumonia 9.8
605 opisthorchiasis 9.8
606 facial paralysis 9.8
607 schistosomiasis 9.8
608 reye syndrome 9.8
609 cholera 9.8
610 lymphadenitis 9.8
611 mononeuritis multiplex 9.8
612 thrombocytosis 9.8
613 relapsing polychondritis 9.8
614 kidney cancer 9.8
615 bilirubin metabolic disorder 9.8
616 acalculous cholecystitis 9.8
617 substance abuse 9.8
618 glioblastoma multiforme 9.8
619 acute porphyria 9.8
620 lipomatosis 9.8
621 rhabdomyosarcoma 9.8
622 granulomatous myositis 9.8
623 aortic aneurysm 9.8
624 lactic acidosis 9.8
625 dystonia 9.8
626 subvalvular aortic stenosis 9.8
627 anteroseptal myocardial infarction 9.8
628 eosinophilic pneumonia 9.8
629 lymphopenia 9.8
630 adenoma 9.8
631 b-cell lymphoma 9.8
632 muscular atrophy 9.8
633 chronic kidney disease 9.8
634 cocaine abuse 9.8
635 periodontitis 9.8
636 mucormycosis 9.8
637 collagen disease 9.8
638 neuropathy 9.8
639 neurofibromatosis 9.8
640 croup 9.8
641 allergic asthma 9.8
642 stomatitis 9.8
643 polyarteritis nodosa 9.8
644 miliary tuberculosis 9.8
645 bidirectional tachycardia 9.8
646 chronic active epstein-barr virus infection 9.8
647 diffuse cutaneous systemic sclerosis 9.8
648 haemophilus influenzae 9.8
649 hansen's disease 9.8
650 meningococcal infection 9.8
651 transverse myelitis 9.8
652 fainting 9.8
653 hypoxia 9.8
654 systemic autoimmune disease 9.8
655 cerebrofacial arteriovenous metameric syndrome 9.8
656 rapidly involuting congenital hemangioma 9.8
657 paracetamol poisoning 9.8
658 esophageal cancer 9.7
659 hypercholesterolemia, familial, 1 9.7
660 systemic lupus erythematosus 5 9.7
661 dressler's syndrome 9.7
662 inflammatory spondylopathy 9.7
663 iron metabolism disease 9.7
664 sickle cell disease 9.7
665 neurofibromatosis, type ii 9.6
666 bladder cancer 9.6
667 cardiomyopathy, dilated, 1a 9.6
668 coarctation of aorta 9.6
669 creutzfeldt-jakob disease 9.6
670 periodic fever, familial, autosomal dominant 9.6
671 attention deficit-hyperactivity disorder 9.6
672 ige responsiveness, atopic 9.6
673 kaposi sarcoma 9.6
674 melanoma, uveal 9.6
675 neurofibromatosis, type i 9.6
676 noonan syndrome 1 9.6
677 optic atrophy 1 9.6
678 pemphigus vulgaris, familial 9.6
679 pernicious anemia 9.6
680 retinoblastoma 9.6
681 schizophrenia 9.6
682 storm syndrome 9.6
683 thrombocytopenia 2 9.6
684 thrombocytopenic purpura, autoimmune 9.6
685 thrombophilia due to thrombin defect 9.6
686 digeorge syndrome 9.6
687 torticollis 9.6
688 down syndrome 9.6
689 acrocallosal syndrome 9.6
690 afibrinogenemia, congenital 9.6
691 cleft larynx, posterior 9.6
692 cystic fibrosis 9.6
693 hemochromatosis, type 1 9.6
694 familial mediterranean fever 9.6
695 myxedema 9.6
696 netherton syndrome 9.6
697 osteogenic sarcoma 9.6
698 hyper-igd syndrome 9.6
699 pulmonary venoocclusive disease 1, autosomal dominant 9.6
700 rhabdomyosarcoma 2 9.6
701 squamous cell carcinoma, head and neck 9.6
702 muscular dystrophy, becker type 9.6
703 sarcoma, synovial 9.6
704 cardiomyopathy, dilated, 3b 9.6
705 hemophilia a 9.6
706 cardiomyopathy, infantile histiocytoid 9.6
707 naxos disease 9.6
708 dermatitis herpetiformis, familial 9.6
709 yemenite deaf-blind hypopigmentation syndrome 9.6
710 ascaris lumbricoides infection 9.6
711 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.6
712 meningioma, radiation-induced 9.6
713 aortic aneurysm, familial thoracic 1 9.6
714 nasopharyngeal carcinoma 9.6
715 meningioma, familial 9.6
716 resting heart rate, variation in 9.6
717 patent ductus arteriosus 1 9.6
718 endometrial cancer 9.6
719 kala-azar 1 9.6
720 sick sinus syndrome 1 9.6
721 acute promyelocytic leukemia 9.6
722 adiponectin, serum level of, quantitative trait locus 1 9.6
723 microvascular complications of diabetes 3 9.6
724 microvascular complications of diabetes 4 9.6
725 microvascular complications of diabetes 6 9.6
726 microvascular complications of diabetes 7 9.6
727 premature ovarian failure 7 9.6
728 muscular dystrophy, congenital, lmna-related 9.6
729 fatty liver disease, nonalcoholic 1 9.6
730 fanconi renotubular syndrome 2 9.6
731 beta-thalassemia 9.6
732 myelodysplastic syndrome 9.6
733 alacrima, achalasia, and mental retardation syndrome 9.6
734 leukemia, acute lymphoblastic 3 9.6
735 hyperprolactinemia 9.6
736 peripheral vascular disease 9.6
737 west syndrome 9.6
738 japanese spotted fever 9.6
739 swine influenza 9.6
740 paralytic poliomyelitis 9.6
741 autosomal recessive disease 9.6
742 diffuse large b-cell lymphoma 9.6
743 sinoatrial node disease 9.6
744 fibroma 9.6
745 aphasia 9.6
746 marantic endocarditis 9.6
747 inguinal hernia 9.6
748 zika fever 9.6
749 anomalous left coronary artery from the pulmonary artery 9.6
750 cardiac tuberculosis 9.6
751 catecholaminergic polymorphic ventricular tachycardia 9.6
752 lymphoproliferative syndrome 9.6
753 hereditary lymphedema i 9.6
754 hepatic veno-occlusive disease 9.6
755 chronic eosinophilic leukemia 9.6
756 col4a1-related familial vascular leukoencephalopathy 9.6
757 thalassemia 9.6
758 pleurisy 9.6
759 nasopharyngitis 9.6
760 rickets 9.6
761 protein-losing enteropathy 9.6
762 fanconi syndrome 9.6
763 acute inferolateral myocardial infarction 9.6
764 thrombotic thrombocytopenic purpura 9.6
765 dirofilariasis 9.6
766 western equine encephalitis 9.6
767 hand, foot and mouth disease 9.6
768 leech infestation 9.6
769 asphyxia neonatorum 9.6
770 hypoparathyroidism 9.6
771 t cell deficiency 9.6
772 cat-scratch disease 9.6
773 tick paralysis 9.6
774 spinal meningioma 9.6
775 epidural abscess 9.6
776 listeriosis 9.6
777 cortical blindness 9.6
778 nephrotic syndrome 9.6
779 optic neuritis 9.6
780 crimean-congo hemorrhagic fever 9.6
781 leukemia 9.6
782 hepatic coma 9.6
783 respiratory syncytial virus infectious disease 9.6
784 hereditary spherocytosis 9.6
785 relapsing fever 9.6
786 tick-borne relapsing fever 9.6
787 hellp syndrome 9.6
788 crescentic glomerulonephritis 9.6
789 hepatic encephalopathy 9.6
790 cholestasis 9.6
791 squamous cell papilloma 9.6
792 childhood type dermatomyositis 9.6
793 pleuropneumonia 9.6
794 hantavirus pulmonary syndrome 9.6
795 avoidant personality disorder 9.6
796 personality disorder 9.6
797 panniculitis 9.6
798 urticaria 9.6
799 limited scleroderma 9.6
800 diffuse scleroderma 9.6
801 squamous cell carcinoma 9.6
802 cheilitis 9.6
803 calcinosis 9.6
804 endodermal sinus tumor 9.6
805 rectum cancer 9.6
806 encephalomalacia 9.6
807 maxillary sinusitis 9.6
808 chronic mucocutaneous candidiasis 9.6
809 intestinal perforation 9.6
810 tularemia 9.6
811 hemorrhagic disease 9.6
812 myeloproliferative neoplasm 9.6
813 keratopathy 9.6
814 arteriosclerosis 9.6
815 central retinal vein occlusion 9.6
816 psychotic disorder 9.6
817 hematologic cancer 9.6
818 papilloma 9.6
819 benign mesothelioma 9.6
820 nonspecific interstitial pneumonia 9.6
821 long qt syndrome 9.6
822 hairy cell leukemia 9.6
823 glucosephosphate dehydrogenase deficiency 9.6
824 anuria 9.6
825 adenocarcinoma 9.6
826 wissler-fanconi syndrome 9.6
827 ascaridiasis 9.6
828 chronic granulomatous disease 9.6
829 histiocytosis 9.6
830 mastocytosis 9.6
831 intermittent claudication 9.6
832 gastric adenocarcinoma 9.6
833 arthropathy 9.6
834 posterior cerebral artery infarction 9.6
835 insulinoma 9.6
836 lung squamous cell carcinoma 9.6
837 liver disease 9.6
838 ebola hemorrhagic fever 9.6
839 clear cell renal cell carcinoma 9.6
840 subacute bacterial endocarditis 9.6
841 secretory meningioma 9.6
842 lymphoplasmacyte-rich meningioma 9.6
843 familial retinoblastoma 9.6
844 uremia 9.6
845 subacute glomerulonephritis 9.6
846 neurotic disorder 9.6
847 demyelinating polyneuropathy 9.6
848 human immunodeficiency virus infectious disease 9.6
849 testicular yolk sac tumor 9.6
850 pulmonary venoocclusive disease 9.6
851 anal squamous cell carcinoma 9.6
852 volkmann contracture 9.6
853 acute pyelonephritis 9.6
854 discrete subaortic stenosis 9.6
855 anterolateral myocardial infarction 9.6
856 apical myocardial infarction 9.6
857 subendocardial myocardial infarction 9.6
858 nephrolithiasis 9.6
859 posterolateral myocardial infarction 9.6
860 lateral myocardial infarction 9.6
861 inherited metabolic disorder 9.6
862 mitochondrial metabolism disease 9.6
863 malignant pleural mesothelioma 9.6
864 gastrointestinal system disease 9.6
865 end stage renal disease 9.6
866 appendicitis 9.6
867 corneal ulcer 9.6
868 bullous pemphigoid 9.6
869 neuromyelitis optica 9.6
870 evans' syndrome 9.6
871 visceral leishmaniasis 9.6
872 carotid artery dissection 9.6
873 diabetes insipidus 9.6
874 bacterial meningitis 9.6
875 cannabis abuse 9.6
876 bronchiectasis 9.6
877 dextrocardia 9.6
878 fasciitis 9.6
879 necrotizing fasciitis 9.6
880 sarcocystosis 9.6
881 heart aneurysm 9.6
882 alopecia 9.6
883 cardiovascular syphilis 9.6
884 waterhouse-friderichsen syndrome 9.6
885 eosinophilia-myalgia syndrome 9.6
886 hypoglycemia 9.6
887 hemophilia 9.6
888 ankrd26-related thrombocytopenia 9.6
889 mitochondrial disorders 9.6
890 acute articular rheumatism 9.6
891 anca-associated vasculitis 9.6
892 aneurysm of sinus of valsalva 9.6
893 autoimmune encephalitis 9.6
894 candida glabrata 9.6
895 catastrophic antiphospholipid syndrome 9.6
896 chronic graft versus host disease 9.6
897 cold agglutinin disease 9.6
898 congenital herpes simplex 9.6
899 congenital rubella 9.6
900 cytomegalic inclusion disease 9.6
901 defective apolipoprotein b-100 9.6
902 glioma 9.6
903 growth hormone deficiency 9.6
904 hashimoto encephalopathy 9.6
905 hereditary amyloidosis 9.6
906 homologous wasting disease 9.6
907 lymphangiectasis 9.6
908 lymphocytic hypophysitis 9.6
909 microscopic polyangiitis 9.6
910 neonatal meningitis 9.6
911 ocular toxoplasmosis 9.6
912 parainfluenza virus type 3 9.6
913 pediatric ulcerative colitis 9.6
914 primary agammaglobulinemia 9.6
915 pseudo-turner syndrome 9.6
916 pure autonomic failure 9.6
917 scleromyxedema 9.6
918 streptococcal group a invasive disease 9.6
919 systemic onset juvenile idiopathic arthritis 9.6
920 tuberculous meningitis 9.6
921 wallerian degeneration 9.6
922 west nile virus encephalitis 9.6
923 critical congenital heart disease 9.6
924 anoxia 9.6
925 dysautonomia 9.6
926 myoclonus 9.6
927 paresthesia 9.6
928 tremor 9.6
929 subacute cutaneous lupus erythematosus 9.6
930 rare cardiomyopathy 9.6
931 glial tumor 9.6
932 qualitative or quantitative defects of dystrophin 9.6
933 unclassified cardiomyopathy 9.6
934 rare hereditary hemochromatosis 9.6
935 hereditary periodic fever syndrome 9.6
936 idiopathic nephrotic syndrome 9.6
937 acute radiation syndrome 9.6
938 neonatal lupus erythematosus 9.6
939 ethylene glycol poisoning 9.6
940 erythrokeratoderma 9.6
941 rare tumor 9.6
942 pediatric systemic lupus erythematosus 9.6
943 thrombotic microangiopathy 9.6

Comorbidity relations with Myocarditis via Phenotypic Disease Network (PDN): (showing 7, show less)


Acute Cystitis Familial Atrial Fibrillation
Generalized Atherosclerosis Heart Disease
Hypertension, Essential Intermediate Coronary Syndrome
Mitral Valve Disease

Graphical network of the top 20 diseases related to Myocarditis:



Diseases related to Myocarditis

Symptoms & Phenotypes for Myocarditis

MGI Mouse Phenotypes related to Myocarditis:

45 (showing 11, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.34 CD40LG CXADR DAG1 DMD DSP HLA-DQB1
2 cellular MP:0005384 10.32 CD40LG CD86 CXADR DAG1 DMD DSP
3 homeostasis/metabolism MP:0005376 10.24 CD40 CD40LG CD55 CD86 CXADR DAG1
4 hematopoietic system MP:0005397 10.22 CD40 CD40LG CD55 CD86 CXADR DMD
5 endocrine/exocrine gland MP:0005379 10.13 CD40 CD40LG CD86 CXADR DMD HLA-DQB1
6 immune system MP:0005387 10.13 CD40 CD40LG CD55 CD86 CXADR DMD
7 mortality/aging MP:0010768 10.13 CD40LG CD55 CXADR DAG1 DMD DSP
8 digestive/alimentary MP:0005381 10.06 CXADR DMD DSP HLA-DQB1 ICAM1 IL6
9 muscle MP:0005369 10 CD55 CD86 CXADR DAG1 DMD DSP
10 nervous system MP:0003631 9.73 CD40 CD40LG CD86 DAG1 DMD DSP
11 respiratory system MP:0005388 9.28 CXADR DMD HLA-DQB1 IL6 MB MYH6

Drugs & Therapeutics for Myocarditis

Drugs for Myocarditis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 170, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oseltamivir Approved Phase 4 204255-11-8, 196618-13-0 65028
2
Adalimumab Approved Phase 4 331731-18-1 16219006
3
Abatacept Approved Phase 4 332348-12-6 10237
4 Immunosuppressive Agents Phase 4
5 Immunologic Factors Phase 4
6 Immunoglobulins Phase 4
7 Antibodies Phase 4
8 Immunoglobulins, Intravenous Phase 4
9 Rho(D) Immune Globulin Phase 4
10 gamma-Globulins Phase 4
11 Vaccines Phase 4
12 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,... Phase 4
13 Sodium-Glucose Transporter 2 Inhibitors Phase 4
14 Hypoglycemic Agents Phase 4
15
Ramipril Approved Phase 3 87333-19-5 5362129
16
Bisoprolol Approved Phase 3 66722-44-9 2405
17
Selenium Approved, Investigational, Vet_approved Phase 3 7782-49-2
18
Captopril Approved Phase 3 62571-86-2 44093
19
Aspirin Approved, Vet_approved Phase 2, Phase 3 50-78-2 2244
20
Angiotensin II Approved, Investigational Phase 3 4474-91-3, 11128-99-7, 68521-88-0 172198
21
Valsartan Approved, Investigational Phase 3 137862-53-4 60846
22 Hematinics Phase 2, Phase 3
23 Ferrosoferric Oxide Phase 2, Phase 3
24 Parenteral Nutrition Solutions Phase 2, Phase 3
25 Neurotransmitter Agents Phase 3
26 Protective Agents Phase 3
27 Adrenergic beta-Antagonists Phase 2, Phase 3
28 Interleukin 1 Receptor Antagonist Protein Phase 2, Phase 3
29 Adrenergic beta-1 Receptor Antagonists Phase 3
30 Adrenergic Antagonists Phase 3
31 Angiotensin-Converting Enzyme Inhibitors Phase 3
32 Sympatholytics Phase 3
33 Adrenergic Agents Phase 3
34
protease inhibitors Phase 3
35 HIV Protease Inhibitors Phase 3
36 Antioxidants Phase 3
37 Trace Elements Phase 3
38 Sodium Selenite Phase 3
39 Nutrients Phase 3
40 Micronutrients Phase 3
41 Anti-Inflammatory Agents Phase 2, Phase 3
42 Antiviral Agents Phase 2, Phase 3
43 Analgesics, Non-Narcotic Phase 2, Phase 3
44 Cyclooxygenase Inhibitors Phase 2, Phase 3
45 Anti-Inflammatory Agents, Non-Steroidal Phase 2, Phase 3
46 Fibrinolytic Agents Phase 2, Phase 3
47 Platelet Aggregation Inhibitors Phase 2, Phase 3
48 Antipyretics Phase 2, Phase 3
49 Antihypertensive Agents Phase 3
50 Angiotensin II Type 1 Receptor Blockers Phase 3
51 Angiotensinogen Phase 3
52 Angiotensin Receptor Antagonists Phase 3
53 LCZ 696 Phase 3
54 Giapreza Phase 3
55
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
56
Lenograstim Approved, Investigational Phase 2 135968-09-1
57
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
58
Clotrimazole Approved, Vet_approved Phase 2 23593-75-1 2812
59
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
60
Epirubicin Approved Phase 2 56420-45-2 41867
61
Valganciclovir Approved, Investigational Phase 2 175865-60-8 64147
62
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
63
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
64
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
65
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
66 Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
67
Evolocumab Approved Phase 2 1256937-27-5
68
Atorvastatin Approved Phase 2 134523-00-5 60823
69
Adenosine Approved, Investigational Phase 2 58-61-7 60961
70 Molgramostim Investigational Phase 2 99283-10-0
71 Pleconaril Investigational Phase 2 153168-05-9
72
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7
73
3,5-diiodothyropropionic acid Investigational Phase 1, Phase 2 1158-10-7
74 Adjuvants, Immunologic Phase 2
75 glucocorticoids Phase 2
76 Antiemetics Phase 2
77 Dermatologic Agents Phase 2
78 Antifungal Agents Phase 2
79 Neuroprotective Agents Phase 2
80 Calcineurin Inhibitors Phase 2
81 Muromonab-CD3 Phase 2
82 Methylprednisolone Acetate Phase 2
83 Anti-Bacterial Agents Phase 2
84 Interleukin-2 Phase 2
85 Antidotes Phase 2
86 Antitubercular Agents Phase 2
87 Chelating Agents Phase 2
88 sodium thiosulfate Phase 2
89
Hydrogen sulfide Phase 2 7783-06-4 402
90 Antimetabolites Phase 2
91 Hypolipidemic Agents Phase 2
92 Lipid Regulating Agents Phase 2
93 Anticholesteremic Agents Phase 2
94 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 2
95 Calcium, Dietary Phase 2
96 Hormones Phase 1, Phase 2
97 Hormone Antagonists Phase 1, Phase 2
98 Pharmaceutical Solutions Phase 2
99 Analgesics Phase 2
100
Calcium Nutraceutical Phase 2 7440-70-2 271
101
Doxorubicin Approved, Investigational Phase 1 23214-92-8 31703
102
Liposomal doxorubicin Phase 1 31703
103 Antibiotics, Antitubercular Phase 1
104
Iron Approved, Experimental 15438-31-0, 7439-89-6 27284 23925
105
Nicotinamide Approved, Investigational Early Phase 1 98-92-0 936
106
Diclofenac Approved, Vet_approved 15307-86-5 3033
107
Risperidone Approved, Investigational 106266-06-2 5073
108
Dopamine Approved 51-61-6, 62-31-7 681